X @The Economist
The Economistยท2025-08-15 15:50
Industry Focus - Drugs targeting rare diseases are now a significant area for biotech companies [1] - The oversight of drugs for rare diseases is becoming increasingly politicized and unstable [1]
Industry Focus - Drugs targeting rare diseases are now a significant area for biotech companies [1] - The oversight of drugs for rare diseases is becoming increasingly politicized and unstable [1]